BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 5785717)

  • 1. [On the presence of soluble antigen in Leishmania tropica major (preliminary report)].
    Sergiev VP; Shuĭkina EE
    Med Parazitol (Mosk); 1969; 38(2):208-12. PubMed ID: 5785717
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of the dose of Leishmania tropica major culture on antibody formation in mice with cutaneous leishmaniasis].
    Dobrzhanskaia RS
    Med Parazitol (Mosk); 1977; 46(4):454-61. PubMed ID: 927378
    [No Abstract]   [Full Text] [Related]  

  • 3. [The complement fixation test in leishmaniasis. Comparison between an antigen extracted from leishmania cultures and one extracted from BCG].
    Mansueto S; Migneco G; La Cascia C
    Minerva Med; 1979 Sep; 70(38):2611-4. PubMed ID: 384298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of transfer factor. In vitro lymphoblast transformation of peripheral lymphocytes to Leishmania major antigen in the presence of transfer factor.
    Sharma MK; Anaraki F; Ala F
    Scand J Immunol; 1977; 6(11):1101-6. PubMed ID: 74087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular destruction of Leishmania donovani and Leishmania tropica amastigotes by activated macrophages: dissociation of these microbicidal effector activities in vitro.
    Hockmeyer WT; Walters D; Gore RW; Williams JS; Fortier AH; Nacy CA
    J Immunol; 1984 Jun; 132(6):3120-5. PubMed ID: 6725948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparative serologic study of Leishmania tropica major and Leishmania tropics minor].
    Aliev EI; Saf'ianova VM; Nadzhafov AIu; Gasan-zade GB
    Med Parazitol (Mosk); 1972; 41(5):531-6. PubMed ID: 4653698
    [No Abstract]   [Full Text] [Related]  

  • 7. Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH.
    Liew FY; Howard JG; Hale C
    J Immunol; 1984 Jan; 132(1):456-61. PubMed ID: 6228580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of protein antigens of Leishmania tropica isolates.
    Handman E; Mitchell GF; Goding JW
    J Immunol; 1981 Feb; 126(2):508-12. PubMed ID: 7451987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced susceptibility of thymectomized mice to infection with Leishmania tropica.
    Preston PM; Tsega E; Dumonde DC
    Trans R Soc Trop Med Hyg; 1971; 65(1):18. PubMed ID: 5092415
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoclonal antibodies specific for Leishmania tropica. I. Characterization of antigens associated with stage- and species-specific determinants.
    Jaffe CL; McMahon-Pratt D
    J Immunol; 1983 Oct; 131(4):1987-93. PubMed ID: 6194223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Killing of Leishmania tropica amastigotes by factors in normal human serum.
    Hoover DL; Berger M; Nacy CA; Hockmeyer WT; Meltzer MS
    J Immunol; 1984 Feb; 132(2):893-7. PubMed ID: 6690622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity.
    Titus RG; Lima GC; Engers HD; Louis JA
    J Immunol; 1984 Sep; 133(3):1594-600. PubMed ID: 6205088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-reactive gamma delta T cells in human leishmaniasis.
    Russo DM; Armitage RJ; Barral-Netto M; Barral A; Grabstein KH; Reed SG
    J Immunol; 1993 Oct; 151(7):3712-8. PubMed ID: 8376802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmania mexicana and Leishmania tropica: cross immunity in C57BL/6 mice.
    Pérez H; Arredondo B; Machado R
    Exp Parasitol; 1979 Aug; 48(1):9-14. PubMed ID: 88370
    [No Abstract]   [Full Text] [Related]  

  • 15. Leishmanial amastigote antigen P-2 induces major histocompatibility complex class II-dependent natural killer-cell reactivity in cells from healthy donors.
    Nylén S; Maasho K; McMahon-Pratt D; Akuffo H
    Scand J Immunol; 2004 Mar; 59(3):294-304. PubMed ID: 15030581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of Langerhans cells in the immunity of leishmaniasis].
    Zuluaga M; Robledo SM
    Biomedica; 2004 Sep; 24(3):302-17. PubMed ID: 15551883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating antibodies in cutaneous leishmaniasis: their detection by immunofluorescence.
    Matossian RM; Kurban AK; Malak JA
    Trans R Soc Trop Med Hyg; 1975; 69(5-6):450-2. PubMed ID: 779154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic immunization against experimental leishmaniasis. II. Further characterization of the protective immunity against fatal Leishmania tropica infection induced by irradiated promastigotes.
    Howard JG; Liew FY; Hale C; Nicklin S
    J Immunol; 1984 Jan; 132(1):450-5. PubMed ID: 6197456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice.
    Ahmed SB; Touihri L; Chtourou Y; Dellagi K; Bahloul C
    Vaccine; 2009 Jan; 27(1):99-106. PubMed ID: 18951941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of integral membrane proteins of Leishmania promastigotes and evaluation of their prophylactic potential in hamsters against experimental visceral leishmaniasis.
    Garg R; Srivastava JK; Pal A; Naik S; Dube A
    Vaccine; 2005 Jan; 23(9):1189-96. PubMed ID: 15629362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.